<DOC>
	<DOCNO>NCT00886405</DOCNO>
	<brief_summary>Nitroglycerin increase effectiveness treatment induction chemotherapy concurrent chemo-radiotherapy reduce chemo-radio resistance increase oxygen pressure tumoral tissue . The combination treatment nitroglycerin chemotherapy result longer disease-free over-all survival patient locally advance NSCLC</brief_summary>
	<brief_title>Concurrent Chemotherapy Radiotherapy With Nitroglycerin Patients With Locally Advanced Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>Nitroglycerin decrease hypoxia-induced resistance antitumor drug due inhibition Hypoxia Inducible Factor alfa ( HIF-1Î± ) , increase oxygen pressure tumoral tissue augment tumor blood flow , increase apoptosis , activation p53 , induces cellular growth inhibition . Randomized study show addition transdermal nitroglycerin non small cell lung cancer ( NSCLC ) patient metastasis treat vinorelbine cisplatin achieve significantly well global response treatment conventional treatment</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Nitroglycerin</mesh_term>
	<criteria>Histopathologic diagnosis non smallcell lung cancer Clinical stage IIIA and/or IIIB without pleural effusion ECOG functional status 0 1 No renal function alteration ( GFR &gt; 50 % ) No hepatic function alteration ( ALT AST less 2 time normal value ) Leucocytes 2,000/mcl Hemoglobin 10mg/dL Platelets 100,000/mcl Ischemic heart disease Abnormal electrocardiogram</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Nitroglycerin</keyword>
	<keyword>Locally advanced non small-cell lung cancer</keyword>
	<keyword>Vascular endothelial growth factor</keyword>
	<keyword>Hypoxia Inducible Factor</keyword>
	<keyword>Clinical stage IIIA and/or IIIB ( without pleural effusion )</keyword>
</DOC>